2621.Hk
2621.HK operates in the life and health insurance sector, providing insurance products and services to customers in China and potentially other markets.
Business. 2621.HK operates in the life and health insurance sector, providing insurance products and services to customers in China and potentially other markets.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
2621.HK operates in the life and health insurance sector, providing insurance products and services to customers in China and potentially other markets.
2621.HK maintains a strong liquidity position, with a current ratio of 1.68 and a low debt-to-equity ratio of 0.01, indicating minimal leverage and a conservative capital structure. The company's price-to-book ratio of 0.55 and price-to-tangible-book ratio of 0.55 suggest that the market values the company at a discount to its book value, potentially reflecting market skepticism or undervaluation.
In terms of profitability, 2621.HK demonstrates a return on equity (ROE) of 60.58% and a return on assets (ROA) of 32.95%, both of which are strong indicators of efficient capital utilization and profitability. These metrics are well above the typical thresholds for the insurance industry, suggesting that the company is outperforming its peers in generating returns from its equity and asset base.
The company's revenue concentration is not explicitly detailed in the available data, but as a life and health insurance provider, it is likely exposed to domestic Chinese markets. Given the lack of segment or geographic breakdown in the provided data, it is difficult to assess the extent of geographic diversification or the risk associated with over-reliance on a single market.
2621.HK is positioned for growth, with a strong net income of 793.32 million CNY and a gross profit of 482.85 million CNY. While specific growth projections for the next fiscal year are not provided, the company's current financial performance suggests a stable and potentially growing revenue stream. The company's low liquidity and dilution risk, as per the risk assessment, further supports a positive outlook for near-term financial stability.
The risk assessment for 2621.HK indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's conservative capital structure and strong profitability metrics contribute to a favorable risk profile. Additionally, the absence of dilution potential in the basic shares and the low debt levels suggest that the company is not under pressure to issue new shares or take on additional debt in the near term.
Recent events and filings for 2621.HK do not indicate any significant changes or risks that would impact the company's operations or financial health. The company's latest financial report, as of the most recent data available, shows a stable and profitable performance, with no signs of distress or major operational challenges.
- 2621.HK has a strong liquidity position with a current ratio of 1.68 and a low debt-to-equity ratio of 0.01.
- The company's return on equity (60.58%) and return on assets (32.95%) are significantly higher than typical industry benchmarks.
- The company's market valuation, as indicated by a price-to-book ratio of 0.55, suggests it is undervalued relative to its book value.
- 2621.HK is not currently facing liquidity or dilution risks, with no immediate filing-based flags detected.
- The company's strong net income and gross profit indicate a stable and potentially growing revenue stream.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 2621.HK Market data — financials · 2026-05-26